Skip to main content
. 2019 Mar 28;30(2):193–200. doi: 10.1007/s13337-019-00517-6

Fig. 1.

Fig. 1

The association between high expression of GPC3 and OS in patients with HCC. OS was reported in 14 studies with a total of 2432 HCC patients. Because of the heterogeneity in the study, pooled HR was calculated by the random effect model. The summary HR and 95% CIs were shown. CI confidence interval, GPC3 glypican-3, HCC hepatocellular carcinoma, HR hazard ratio